Bayer Eylea 8 mg approved in EU for treatment of two major retinal diseases Ruchika Sharma11 Jan 2024 3:30 PM ISTBerlin: Bayer has announced that the European Commission has granted marketing authorization in the European Union (EU) for new Eylea 8 mg...
Unichem Labs bags USFDA nod for hypertension drug Doxazosin Ruchika Sharma11 Jan 2024 2:27 PM ISTThe product will be commercialized from Unichem's Goa Plant.
India to demand faster USFDA inspections of pharma firms at Trade Policy Forum meet Ruchika Sharma11 Jan 2024 1:30 PM ISTNew Delhi: India will strongly demand fast-tracking American health regulator's USFDA inspections, or audit of domestic pharma firms, lifting...
JnJ to acquire Ambrx Biopharma for USD 2 billion Ruchika Sharma11 Jan 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Ambrx Biopharma, Inc., or Ambrx, a...
Lupin unveils smoking cessation tablets Varenicline in US Ruchika Sharma11 Jan 2024 11:19 AM ISTIt is indicated for use as an aid to smoking cessation treatment.
Merck to acquire Harpoon Therapeutics for USD 680 million Ruchika Sharma10 Jan 2024 4:31 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Harpoon Therapeutics, Inc. have announced that the companies have...
Novartis in advanced talks to buy Cytokinetics: Source Ruchika Sharma10 Jan 2024 3:30 PM ISTAccess to Cytokinetics products would help Novartis offset the expected loss of U.S. exclusivity of Entresto, its key drug in this field, said...
USFDA approves Medtronic Percept RC Deep Brain Stimulation system Ruchika Sharma10 Jan 2024 2:30 PM ISTDublin: Medtronic plc has announced the U.S. Food and Drug Administration (FDA) approval of its Percept RC Deep Brain Stimulation (DBS) system....
Sanofi names Brian Foard as head of Specialty Care Global Business Unit Ruchika Sharma10 Jan 2024 1:30 PM ISTParis: Brian Foard, a healthcare industry veteran and Sanofi leader in the U.S., has been named Head of the company's Specialty Care Global...
Pfizer-Genmab Tivdak application accepted for priority review by USFDA for cervical cancer Ruchika Sharma10 Jan 2024 12:30 PM ISTNew York: Pfizer Inc. and Genmab A/S have announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental...
Lupin unveils Bromfenac Ophthalmic Solution in US Ruchika Sharma10 Jan 2024 11:28 AM ISTIt is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
CDSCO Panel grants J&J Protocol Amendment proposal to study anticancer drug Amivantamab and Lazertinib Dr. Divya Colin9 Jan 2024 5:45 PM ISTNew Delhi: Regarding the study of Amivantamab and Lazertinib in combination with platinum-based chemotherapy compared with platinum-based chemotherapy...
